Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of[...]
Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of[...]
03/20/2024 | Press release | Distributed by Public on 03/20/2024 11:12
Please select the service you want to use:
Smartlinks | Getlink SE | News | Local News | Company News | Top Company News | Business Announcement | Products and Services | New Products | Transportation | Rail Transportation | Securities Issuers | Railway Infrastructure Management Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | Tradegate Exchange | Euronext Paris | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Aquis Exchange | SIGMA X MTF | Equiduct | Euronext Block MTF | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact